SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection

Evidence-Based GI: An ACG Publication and Podcast - A podcast by American College of Gastroenterology - Wednesdays

Associate Editor Jessica Allegretti, MD, MPH and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi FACG discuss “SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection” by Feuerstadt et al, published in N Engl J Med [2022;386(3):220-229]. https://pubmed.ncbi.nlm.nih.gov/35045228/